ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

DCCP Board Gives Concept Approval to Noncompeting Contracts

June 17, 1983

New Coalition To Lobby for Prevention

November 24, 1978

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered

February 13, 1987

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

RFPs Available

May 5, 2000